Genoray Balance Sheet Health
Financial Health criteria checks 5/6
Genoray has a total shareholder equity of ₩93.0B and total debt of ₩19.4B, which brings its debt-to-equity ratio to 20.8%. Its total assets and total liabilities are ₩133.1B and ₩40.1B respectively. Genoray's EBIT is ₩10.8B making its interest coverage ratio 56.2. It has cash and short-term investments of ₩15.1B.
Key information
20.8%
Debt to equity ratio
₩19.35b
Debt
Interest coverage ratio | 56.2x |
Cash | ₩15.14b |
Equity | ₩93.01b |
Total liabilities | ₩40.07b |
Total assets | ₩133.08b |
Recent financial health updates
Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?
Mar 01We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt
Nov 30Recent updates
Genoray's (KOSDAQ:122310) Soft Earnings Are Actually Better Than They Appear
Nov 21Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems
Mar 28Does Genoray Co., Ltd. (KOSDAQ:122310) Have A Place In Your Dividend Portfolio?
Apr 12Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?
Mar 01We Like Genoray's (KOSDAQ:122310) Returns And Here's How They're Trending
Feb 11Is Genoray Co., Ltd.'s (KOSDAQ:122310) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 27Is Genoray Co., Ltd. (KOSDAQ:122310) A Smart Choice For Dividend Investors?
Jan 12Genoray Co., Ltd. (KOSDAQ:122310) Looks Interesting, And It's About To Pay A Dividend
Dec 24A Look At The Fair Value Of Genoray Co., Ltd. (KOSDAQ:122310)
Dec 15We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt
Nov 30Financial Position Analysis
Short Term Liabilities: A122310's short term assets (₩74.7B) exceed its short term liabilities (₩32.4B).
Long Term Liabilities: A122310's short term assets (₩74.7B) exceed its long term liabilities (₩7.6B).
Debt to Equity History and Analysis
Debt Level: A122310's net debt to equity ratio (4.5%) is considered satisfactory.
Reducing Debt: A122310's debt to equity ratio has increased from 16.8% to 20.8% over the past 5 years.
Debt Coverage: A122310's debt is well covered by operating cash flow (37%).
Interest Coverage: A122310's interest payments on its debt are well covered by EBIT (56.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 18:29 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genoray Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jongsun Park | Eugene Investment & Securities Co Ltd. |
Joo-won Ahn | Yuanta Securities Korea Co., Ltd. |